armagan aral atx-oros-mph functional outcomes

Published: 31 August 2021| Version 1 | DOI: 10.17632/836kn5j47p.1
armagan aral


This retrospective study was carried out to compare the functional outcomes of the oral delivery system of osmotic release methylphenidate (OROS-MPH) and atomoxetine (ATX). Linear mixed-effects models were performed with outcome measures of difference in ADHD symptoms and functional impairment. In terms of total and school function subscales, OROS-MPH was superior to ATX (difference in slope is β = 0.09 and β = 0.15 in successive visits, p < .001 respectively). However, ATX was superior on the family function subscale ( slope difference is β = 0.09, p < .001).